Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
07 Dec 2025
1.
New drug combination shows good results in patients with HPV-negative head and neck cancer
2.
A new drug delivery system may help patients with a rare eye cancer
3.
C/EBP? works in tandem with MYB to sustain AML cells' oncogenic program.
4.
What Dolph Lundgren's journey from terminal diagnosis to 'cancer free' can tell us about cancer care
5.
Prostate cancer death risk is higher in late teens and early 20s weight gain.
1.
Demystifying Hypereosinophilic Syndrome: Symptoms, Diagnosis, and Treatment Options
2.
Claudin-18.2 in Gastric Cancer: Tumor-Stroma Crosstalk and Disease Progression
3.
Chronic Cancer Survivorship: Managing Long-Term Outcomes with Precision Care
4.
Anemia in Older Adults: Causes, Clinical Impact, and Evidence-Based Management
5.
Essential Oncology Updates: Diagnosis, Treatment Advances, Tools & Education Resources
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- The Conclusion
2.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
3.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge